Titre : Metalloproteases

Metalloproteases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Metalloproteases : Questions médicales les plus fréquentes", "headline": "Metalloproteases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Metalloproteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-14", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Metalloproteases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Peptide hydrolases", "url": "https://questionsmedicales.fr/mesh/D010447", "about": { "@type": "MedicalCondition", "name": "Peptide hydrolases", "code": { "@type": "MedicalCode", "code": "D010447", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Metalloendopeptidases", "alternateName": "Metalloendopeptidases", "url": "https://questionsmedicales.fr/mesh/D008666", "about": { "@type": "MedicalCondition", "name": "Metalloendopeptidases", "code": { "@type": "MedicalCode", "code": "D008666", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Collagenases", "alternateName": "Collagenases", "url": "https://questionsmedicales.fr/mesh/D017364", "about": { "@type": "MedicalCondition", "name": "Collagenases", "code": { "@type": "MedicalCode", "code": "D017364", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.205" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Microbial collagenase", "alternateName": "Microbial Collagenase", "url": "https://questionsmedicales.fr/mesh/D003012", "about": { "@type": "MedicalCondition", "name": "Microbial collagenase", "code": { "@type": "MedicalCode", "code": "D003012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.205.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Microbial collagenase", "alternateName": "Microbial Collagenase", "url": "https://questionsmedicales.fr/mesh/D003012", "about": { "@type": "MedicalCondition", "name": "Microbial collagenase", "code": { "@type": "MedicalCode", "code": "D003012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.205.500" } } }, { "@type": "MedicalWebPage", "name": "Enzymes de conversion de l'endothéline", "alternateName": "Endothelin-Converting Enzymes", "url": "https://questionsmedicales.fr/mesh/D000072396", "about": { "@type": "MedicalCondition", "name": "Enzymes de conversion de l'endothéline", "code": { "@type": "MedicalCode", "code": "D000072396", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.229" } } }, { "@type": "MedicalWebPage", "name": "Gelatinases", "alternateName": "Gelatinases", "url": "https://questionsmedicales.fr/mesh/D018093", "about": { "@type": "MedicalCondition", "name": "Gelatinases", "code": { "@type": "MedicalCode", "code": "D018093", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.252" } } }, { "@type": "MedicalWebPage", "name": "Insulinase", "alternateName": "Insulysin", "url": "https://questionsmedicales.fr/mesh/D007339", "about": { "@type": "MedicalCondition", "name": "Insulinase", "code": { "@type": "MedicalCode", "code": "D007339", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.300" } } }, { "@type": "MedicalWebPage", "name": "Lysostaphin", "alternateName": "Lysostaphin", "url": "https://questionsmedicales.fr/mesh/D008248", "about": { "@type": "MedicalCondition", "name": "Lysostaphin", "code": { "@type": "MedicalCode", "code": "D008248", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.452" } } }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinases", "alternateName": "Matrix Metalloproteinases", "url": "https://questionsmedicales.fr/mesh/D020782", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinases", "code": { "@type": "MedicalCode", "code": "D020782", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 14", "alternateName": "Matrix Metalloproteinase 14", "url": "https://questionsmedicales.fr/mesh/D053511", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 14", "code": { "@type": "MedicalCode", "code": "D053511", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.500" } } }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 15", "alternateName": "Matrix Metalloproteinase 15", "url": "https://questionsmedicales.fr/mesh/D053517", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 15", "code": { "@type": "MedicalCode", "code": "D053517", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.625" } } }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 16", "alternateName": "Matrix Metalloproteinase 16", "url": "https://questionsmedicales.fr/mesh/D053513", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 16", "code": { "@type": "MedicalCode", "code": "D053513", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 14", "alternateName": "Matrix Metalloproteinase 14", "url": "https://questionsmedicales.fr/mesh/D053511", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 14", "code": { "@type": "MedicalCode", "code": "D053511", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.500" } } }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 15", "alternateName": "Matrix Metalloproteinase 15", "url": "https://questionsmedicales.fr/mesh/D053517", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 15", "code": { "@type": "MedicalCode", "code": "D053517", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.625" } } }, { "@type": "MedicalWebPage", "name": "Matrix metalloproteinase 16", "alternateName": "Matrix Metalloproteinase 16", "url": "https://questionsmedicales.fr/mesh/D053513", "about": { "@type": "MedicalCondition", "name": "Matrix metalloproteinase 16", "code": { "@type": "MedicalCode", "code": "D053513", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.525.300.750" } } }, { "@type": "MedicalWebPage", "name": "Procollagen peptidase", "alternateName": "Procollagen N-Endopeptidase", "url": "https://questionsmedicales.fr/mesh/D011348", "about": { "@type": "MedicalCondition", "name": "Procollagen peptidase", "code": { "@type": "MedicalCode", "code": "D011348", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.664" } } }, { "@type": "MedicalWebPage", "name": "Bacillus thermoproteolyticus neutral proteinase", "alternateName": "Thermolysin", "url": "https://questionsmedicales.fr/mesh/D013820", "about": { "@type": "MedicalCondition", "name": "Bacillus thermoproteolyticus neutral proteinase", "code": { "@type": "MedicalCode", "code": "D013820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.374.827" } } } ] }, { "@type": "MedicalWebPage", "name": "Metalloexopeptidases", "alternateName": "Metalloexopeptidases", "url": "https://questionsmedicales.fr/mesh/D045727", "about": { "@type": "MedicalCondition", "name": "Metalloexopeptidases", "code": { "@type": "MedicalCode", "code": "D045727", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Carboxypeptidases A", "alternateName": "Carboxypeptidases A", "url": "https://questionsmedicales.fr/mesh/D043422", "about": { "@type": "MedicalCondition", "name": "Carboxypeptidases A", "code": { "@type": "MedicalCode", "code": "D043422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.350" } } }, { "@type": "MedicalWebPage", "name": "Cystinyl aminopeptidase", "alternateName": "Cystinyl Aminopeptidase", "url": "https://questionsmedicales.fr/mesh/D010122", "about": { "@type": "MedicalCondition", "name": "Cystinyl aminopeptidase", "code": { "@type": "MedicalCode", "code": "D010122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.400" } } }, { "@type": "MedicalWebPage", "name": "Glutamate carboxypeptidase II", "alternateName": "Glutamate Carboxypeptidase II", "url": "https://questionsmedicales.fr/mesh/D043425", "about": { "@type": "MedicalCondition", "name": "Glutamate carboxypeptidase II", "code": { "@type": "MedicalCode", "code": "D043425", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.500" } } }, { "@type": "MedicalWebPage", "name": "Glutamyl aminopeptidase", "alternateName": "Glutamyl Aminopeptidase", "url": "https://questionsmedicales.fr/mesh/D043384", "about": { "@type": "MedicalCondition", "name": "Glutamyl aminopeptidase", "code": { "@type": "MedicalCode", "code": "D043384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.600" } } }, { "@type": "MedicalWebPage", "name": "Leucyl Aminopeptidase", "alternateName": "Leucyl Aminopeptidase", "url": "https://questionsmedicales.fr/mesh/D007931", "about": { "@type": "MedicalCondition", "name": "Leucyl Aminopeptidase", "code": { "@type": "MedicalCode", "code": "D007931", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.700" } } }, { "@type": "MedicalWebPage", "name": "Lysine carboxypeptidase", "alternateName": "Lysine Carboxypeptidase", "url": "https://questionsmedicales.fr/mesh/D001121", "about": { "@type": "MedicalCondition", "name": "Lysine carboxypeptidase", "code": { "@type": "MedicalCode", "code": "D001121", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.656.675.555.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Metalloproteases", "alternateName": "Metalloproteases", "code": { "@type": "MedicalCode", "code": "D045726", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tania Fontanil", "url": "https://questionsmedicales.fr/author/Tania%20Fontanil", "affiliation": { "@type": "Organization", "name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain." } }, { "@type": "Person", "name": "Yamina Mohamedi", "url": "https://questionsmedicales.fr/author/Yamina%20Mohamedi", "affiliation": { "@type": "Organization", "name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain." } }, { "@type": "Person", "name": "Teresa Cobo", "url": "https://questionsmedicales.fr/author/Teresa%20Cobo", "affiliation": { "@type": "Organization", "name": "Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Universidad de Oviedo, 33006 Oviedo, Spain." } }, { "@type": "Person", "name": "Santiago Cal", "url": "https://questionsmedicales.fr/author/Santiago%20Cal", "affiliation": { "@type": "Organization", "name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain." } }, { "@type": "Person", "name": "Álvaro J Obaya", "url": "https://questionsmedicales.fr/author/%C3%81lvaro%20J%20Obaya", "affiliation": { "@type": "Organization", "name": "Departamento de Biología Funcional, Área de Fisiología, Universidad de Oviedo, 33006 Oviedo, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Ensuring environmental inclusion in developing countries: the role of macroeconomic policies.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36474034", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-022-24596-z" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the quality of health technology assessment reports in a developing country.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37553743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26719/emhj.22.017" } }, { "@type": "ScholarlyArticle", "name": "Investigating the impact of air pollution in selected African developing countries.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-26998-z" } }, { "@type": "ScholarlyArticle", "name": "The national health program for vitamin D supplementation in a developing country.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36963898", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clnesp.2023.01.012" } }, { "@type": "ScholarlyArticle", "name": "Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36395260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277493" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Peptide hydrolases", "item": "https://questionsmedicales.fr/mesh/D010447" }, { "@type": "ListItem", "position": 6, "name": "Metalloproteases", "item": "https://questionsmedicales.fr/mesh/D045726" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Metalloproteases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Metalloproteases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Metalloproteases", "description": "Comment diagnostiquer une dysfonction des métalloprotéases ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes imageries sont-elles utiles pour le diagnostic ?\nQuels tests génétiques sont disponibles ?\nComment évaluer l'activité enzymatique ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Metalloproteases", "description": "Quels symptômes indiquent une surproduction de métalloprotéases ?\nLes symptômes varient-ils selon le type de métalloprotéases ?\nQuels signes cliniques sont associés à une déficience ?\nLes symptômes sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec l'âge ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Metalloproteases", "description": "Comment prévenir les maladies liées aux métalloprotéases ?\nLes suppléments nutritionnels sont-ils utiles ?\nL'évitement de certains aliments est-il recommandé ?\nLe contrôle du stress est-il important ?\nLes examens réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Metalloproteases", "description": "Quels traitements ciblent les métalloprotéases ?\nLes thérapies géniques sont-elles une option ?\nComment les anti-inflammatoires aident-ils ?\nLes traitements sont-ils personnalisés ?\nQuels sont les effets secondaires des inhibiteurs ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Metalloproteases", "description": "Quelles complications peuvent survenir avec une suractivité ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles prévisibles ?\nQuelles sont les complications liées à une déficience ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Metalloproteases", "description": "Quels facteurs augmentent le risque de dysfonction ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLe stress chronique influence-t-il le risque ?\nL'exposition à des toxines est-elle un facteur ?", "url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Developing+Countries&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des métalloprotéases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des biopsies tissulaires peuvent évaluer l'activité des métalloprotéases." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de métalloprotéases dans le sérum ou les tissus peuvent servir de marqueurs diagnostiques." } }, { "@type": "Question", "name": "Les imageries sont-elles utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'imagerie peut aider à visualiser les tissus affectés par des déséquilibres enzymatiques." } }, { "@type": "Question", "name": "Quels tests génétiques sont disponibles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent identifier des mutations affectant la production de métalloprotéases." } }, { "@type": "Question", "name": "Comment évaluer l'activité enzymatique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques spécifiques mesurent l'activité des métalloprotéases dans les échantillons." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surproduction de métalloprotéases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une inflammation, des douleurs articulaires et des lésions tissulaires peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de métalloprotéases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types de métalloprotéases peuvent causer des symptômes variés selon les tissus affectés." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à une déficience ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une cicatrisation lente et des anomalies dans la matrice extracellulaire peuvent être observées." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certaines dysfonctions peuvent être asymptomatiques jusqu'à des stades avancés." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'activité des métalloprotéases peut augmenter avec l'âge, aggravant les symptômes dégénératifs." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux métalloprotéases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Les suppléments nutritionnels sont-ils utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les antioxydants, peuvent soutenir la fonction des métalloprotéases." } }, { "@type": "Question", "name": "L'évitement de certains aliments est-il recommandé ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, réduire les aliments pro-inflammatoires peut aider à réguler l'activité des métalloprotéases." } }, { "@type": "Question", "name": "Le contrôle du stress est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut influencer l'activité des métalloprotéases, donc sa gestion est cruciale." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers peuvent aider à détecter précocement des déséquilibres enzymatiques." } }, { "@type": "Question", "name": "Quels traitements ciblent les métalloprotéases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques des métalloprotéases sont utilisés pour traiter certaines maladies." } }, { "@type": "Question", "name": "Les thérapies géniques sont-elles une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique peut corriger des mutations affectant la production de métalloprotéases." } }, { "@type": "Question", "name": "Comment les anti-inflammatoires aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation causée par une suractivité des métalloprotéases." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction du type de métalloprotéases impliqué." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des inhibiteurs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs peuvent causer des effets secondaires comme des troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une suractivité ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies dégénératives, comme l'arthrite, peuvent résulter d'une suractivité des métalloprotéases." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des douleurs chroniques et une mobilité réduite, affectant la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles prévisibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévisibles en surveillant les niveaux d'activité enzymatique." } }, { "@type": "Question", "name": "Quelles sont les complications liées à une déficience ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une cicatrisation lente et des infections peuvent survenir en raison d'une déficience en métalloprotéases." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de dysfonction ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le mode de vie sédentaire et une alimentation déséquilibrée augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies liées aux métalloprotéases peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut exacerber l'activité des métalloprotéases et augmenter les maladies associées." } }, { "@type": "Question", "name": "Le stress chronique influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'équilibre des métalloprotéases, augmentant le risque de maladies." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines environnementales peut affecter l'activité des métalloprotéases." } } ] } ] }

Sous-catégories

20 au total
└─

Metalloendopeptidases

Metalloendopeptidases D008666 - D08.811.277.656.675.374
└─

Metalloexopeptidases

Metalloexopeptidases D045727 - D08.811.277.656.675.555
└─└─

Collagenases

Collagenases D017364 - D08.811.277.656.675.374.205
└─└─

Enzymes de conversion de l'endothéline

Endothelin-Converting Enzymes D000072396 - D08.811.277.656.675.374.229
└─└─

Gelatinases

Gelatinases D018093 - D08.811.277.656.675.374.252
└─└─

Insulinase

Insulysin D007339 - D08.811.277.656.675.374.300
└─└─

Lysostaphin

Lysostaphin D008248 - D08.811.277.656.675.374.452
└─└─

Matrix metalloproteinases

Matrix Metalloproteinases D020782 - D08.811.277.656.675.374.525
└─└─

Procollagen peptidase

Procollagen N-Endopeptidase D011348 - D08.811.277.656.675.374.664
└─└─

Bacillus thermoproteolyticus neutral proteinase

Thermolysin D013820 - D08.811.277.656.675.374.827
└─└─

Carboxypeptidases A

Carboxypeptidases A D043422 - D08.811.277.656.675.555.350
└─└─

Cystinyl aminopeptidase

Cystinyl Aminopeptidase D010122 - D08.811.277.656.675.555.400
└─└─

Glutamate carboxypeptidase II

Glutamate Carboxypeptidase II D043425 - D08.811.277.656.675.555.500
└─└─

Glutamyl aminopeptidase

Glutamyl Aminopeptidase D043384 - D08.811.277.656.675.555.600
└─└─

Leucyl Aminopeptidase

Leucyl Aminopeptidase D007931 - D08.811.277.656.675.555.700
└─└─

Lysine carboxypeptidase

Lysine Carboxypeptidase D001121 - D08.811.277.656.675.555.750
└─└─└─

Microbial collagenase

Microbial Collagenase D003012 - D08.811.277.656.675.374.205.500
└─└─└─└─

Matrix metalloproteinase 14

Matrix Metalloproteinase 14 D053511 - D08.811.277.656.675.374.525.300.500
└─└─└─└─

Matrix metalloproteinase 15

Matrix Metalloproteinase 15 D053517 - D08.811.277.656.675.374.525.300.625
└─└─└─└─

Matrix metalloproteinase 16

Matrix Metalloproteinase 16 D053513 - D08.811.277.656.675.374.525.300.750

Sources (10000 au total)

Evaluating the quality of health technology assessment reports in a developing country.

No single method of health technology assessment (HTA) can meet all the policy- and decision-making needs in a country. However, there should be minimum criteria for performing HTA worldwide, and many... This study aimed to assess the quality of HTA reports in the Islamic Republic of Iran.... We examined all the HTA research reports published by the Iranian HTA office up to 2020, using the International Network of Agencies for Health Technology Assessment checklist for quality assessment.... A total of 97 reports were examined, of which only 10.0% provided complete and appropriate contact details for further information and 5.6% clearly stated a conflict of interest. In 87.78% of the repo... We recommend that minimum standards be established for the HTA process so that healthcare policy- and decision-makers can make reliable decisions on the basis of the HTA reports....

The national health program for vitamin D supplementation in a developing country.

Previous studies have reported a high frequency of vitamin D deficiency (VDD) among different age groups in Iran.... In this study, the current coverage, status of vitamin D supplement taking, and program efficacy have been evaluated by the Office of Nutrition Department Society in Iran since 2014.... This study was conducted in collaboration with the International UNESCO center for Health-Related Basic Sciences and Human Nutrition and the Office of Nutrition Department Society. Sixty three medical... Quantitative analysis showed that availability coverage was 74.96% and 77.56% and accessibility was 80.70% and 83.26% in elderly and middle-aged subjects, respectively in 2018. The acceptability was a... The frequency of taking vitamin D supplements was 27.0% in Iran in 2018. The frequency of taking of vitamin D supplements among vitamin D deficient group (serum vitamin D levels <19.99 ng/ml) was 43.6...

Outcomes of burns patients in a developing country: A single centre's experience.

Pelonomi Tertiary Hospital is the only hospital in the Free State Province with a burns unit. We do not have official data to assess our performance in the management of burns.... To determine the Lethal Area 50 (LA50) index for the Pelonomi Tertiary Hospital's burns unit. Furthermore, to determine the morbidity that affects burns patients at the institution, and the factors as... We used Redcap to capture demographic and clinical data of burn patients admitted to our institution between January 2014 and December 2018. Logistic regression was used to determine significant predi... Our study had a male preponderance, with 59.7% (601) male, 39.9% (401) female and 0.4% (4) missing sex. We had a mean age of 19.4 years, of which 53.38% (n=537) were paediatric patients and 46.32% (n=... The epidemiology of burn patients and working conditions at Pelonomi Tertiary Hospital are similar to other burn units in the country; however, our mortality rate is higher than at most centres. The L...

Technical aspects of inguino scrotal hernia surgery in developing countries.

Technical aspects of inguinoscrotal herniorrhaphy performed in low to middle income countries (LMICs) are described here to help surgeons who will operate on these challenging hernias in austere setti... Technical considerations related to operative repair were delineated with the consensus of 7 surgeons with extensive experience in inguinoscrotal hernia repair in LMICs. Important steps and illustrati... The authors have cumulatively performed over 1775 inguinoscrotal Lichtenstein operations in LMICs. While dedicated, reliable, long-term follow-up is unavailable from LMICs, one author reports outcomes... There is a difference between inguinal hernias found in LMICs and those seen in high-income countries with larger, chronic, and more technically challenging pathology. The consequences of intra-operat...

Internet use and frailty in middle-aged and older adults: findings from developed and developing countries.

With increasing trend of internet use in all age groups, whether internet use can prevent frailty in middle-aged and older adults remains unclear.... Five cohorts, including Health and Retirement Study (HRS), China Health and Retirement Longitudinal Study (CHARLS), the Survey of Health, Ageing and Retirement in Europe (SHARE), English Longitudinal ... In the multicohort study, a total of 155,695 participants were included in main analysis. The proportion of internet use was varied across countries, ranging from 5.56% in China (CHARLS) to 83.46% in ... Our findings highlight the important role of internet use in preventing frailty and recommend more engagements in social communication and activities to avoid social isolation among middle-aged and ol...